CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevin Chan
Galderma R&D
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Galderma Investigational Site
Chomutov, Czechia
- Galderma Investigational Site
Hradec Králové, Czechia
- Galderma Investigational Site
Olomouc, Czechia
- Galderma Investigational Site
Pardubice, Czechia
- Galderma Investigational Site
Prague, Czechia
- Galderma Investigational Site
Augsburg, Germany
- Galderma Investigational Site
Berlin, Germany
- Galderma Investigational Site
Berlin, Germany
- Galderma Investigational Site
Dessau, Germany
- Galderma Investigational Site
Mahlow, Germany
- Galderma Investigational Site
Münster, Germany
- Galderma Investigational Site
Wuppertal, Germany
- Galderma Investigational Site
Balatonfüred, Hungary
- Galderma Investigational Site
Miskolc, Hungary
- Galderma Investigational Site
Pécel, Hungary
- Galderma Investigational Site
Szeged, Hungary
- Galderma Investigational Site
Szekszárd, Hungary
- Galderma Investigational Site
Szolnok, Hungary
- Galderma Investigational Site
Mobile, Alabama, United States
- Galderma Investigational Site
Rogers, Arkansas, United States
- Galderma Investigational Site
Sacramento, California, United States
- Galderma Investigational Site
San Diego, California, United States
- Galderma Investigational Site
Miami, Florida, United States
- Galderma Investigational Site
Miramar, Florida, United States
- Galderma Investigational Site
Newnan, Georgia, United States
- Galderma Investigational Site
Louisville, Kentucky, United States
- Galderma Investigational Site
Albuquerque, New Mexico, United States
- Galderma Investigational Site
New York, New York, United States
- Galderma Investigational Site
High Point, North Carolina, United States
- Galderma Investigational Site
Beachwood, Ohio, United States
- Galderma Investigational Site
Portland, Oregon, United States
- Galderma Investigational Site
Knoxville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Feb 2015
- Primary completion
- 23 Feb 2017
- Completion
- 23 Feb 2017
- Last update posted
- 14 Nov 2019
- Registered enrollment
- 453
- Registry id
- NCT02189629
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.